Posted inAT+

Korea’s ‘innotech’ economy maddens analog Japan

TOKYO – If you’re wondering why South Korea’s economy is outperforming Japan’s in 2021 by such a wide margin, events at drugmaker Celltrion offer some timely clues.

On Monday, the Incheon-based biopharmaceutical outfit announced positive results for an experimental antibody Covid-19 treatment. Clinical trials indicate it reduces the treatment period by nearly five days in Phase 3 global clinical trials.

The breakthrough is a reminder of how neighboring, more developed Japan is conspicuously absent from the vaccinations and therapeutics conversation.

Sign In

We've recently sent you an authentication link. Please, check your inbox!

Sign in with a password below, or sign in using your email.

Get a code sent to your email to sign in, or sign in using a password.

Enter the code you received via email to sign in, or sign in using a password.

Subscribe to our newsletters:

%d bloggers like this: